Analysis and Commentary 4/3/20 Analysis and Commentary 4/3/20 Advocating for a Responsibility-based "Ask" Read More Analysis and Commentary 3/19/20 Analysis and Commentary 3/19/20 Alliance for a Stronger FDA -- FY 21 “Ask” and Explanation Read More Analysis and Commentary 11/22/19 Analysis and Commentary 11/22/19 Time to Talk Turkey ... Once Again Read More Analysis and Commentary 4/13/18 Analysis and Commentary 4/13/18 CBER Today and Tomorrow: Challenges and Opportunities Read More Analysis and Commentary 9/29/17 Analysis and Commentary 9/29/17 Plus ça Change, Plus c'est la Même Chose Read More Analysis and Commentary 7/21/17 Analysis and Commentary 7/21/17 Level Funding for FY 18 Will NOT Allow FDA to Meet All Current Needs Read More Analysis and Commentary 12/5/14 Analysis and Commentary 12/5/14 Why Unfunded Mandates Can Be a Real Problem for FDA Read More
Analysis and Commentary 4/3/20 Analysis and Commentary 4/3/20 Advocating for a Responsibility-based "Ask" Read More
Analysis and Commentary 3/19/20 Analysis and Commentary 3/19/20 Alliance for a Stronger FDA -- FY 21 “Ask” and Explanation Read More
Analysis and Commentary 11/22/19 Analysis and Commentary 11/22/19 Time to Talk Turkey ... Once Again Read More
Analysis and Commentary 4/13/18 Analysis and Commentary 4/13/18 CBER Today and Tomorrow: Challenges and Opportunities Read More
Analysis and Commentary 9/29/17 Analysis and Commentary 9/29/17 Plus ça Change, Plus c'est la Même Chose Read More
Analysis and Commentary 7/21/17 Analysis and Commentary 7/21/17 Level Funding for FY 18 Will NOT Allow FDA to Meet All Current Needs Read More
Analysis and Commentary 12/5/14 Analysis and Commentary 12/5/14 Why Unfunded Mandates Can Be a Real Problem for FDA Read More
